Pacira Biosciences Inc
SWB:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
SWB:82P
|
US |
|
U
|
Upwork Inc
DUS:UP2
|
US |
|
SUESS MicroTec SE
F:SMHN
|
DE |
|
M
|
Mercedes Benz Group AG
XHAM:MBG
|
DE |
|
Volvo AB
OTC:VOLVF
|
SE |
|
L
|
Las Vegas Sands Corp
XMUN:LCR
|
US |
|
H
|
HUYA Inc
F:HY5A
|
CN |
|
Banco de Sabadell SA
F:BDS
|
ES |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 29.36 EUR with a low forecast of 22.54 EUR and a high forecast of 38.71 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
29.36
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 29.36 EUR with a low forecast of 22.54 EUR and a high forecast of 38.71 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
50%
The compound annual growth rate for Operating Income over the next 5 years is 50%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 7 years is 64%.
